HPQ vs LFCR · P/E 8.6, rev $44.52B vs rev $75.5M
HP Inc (HPQ) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
HP Inc (HPQ) is a computer hardware company listed on NYSE.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported HPQ revenue for 2026-07-31 was $44.52B. Net income was $1.66B. Revenue was up 54.3% from 2026-04-30 to 2026-07-31. HPQ currently screens at market cap $21.20B and trailing P/E 8.6.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
HPQ currently screens at market cap $21.20B and trailing P/E 8.6. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the HPQ and LFCR stock pages for the full models.
Not investment advice.